HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease.

AbstractOBJECTIVE:
To determine if D-dimer predicts outcomes in critically ill patients.
DESIGN:
Observational, cohort study.
SETTING:
Medical intensive care unit (MICU) of a tertiary care hospital.
PATIENTS AND PARTICIPANTS:
Seventy-four patients consecutively admitted to the MICU.
INTERVENTIONS:
D-dimer was measured by latex agglutination within 12 h of admission to the MICU.
MEASUREMENTS AND RESULTS:
Of the study population, 43.2% had positive D-dimers. The in-hospital mortality rate in D-dimer positive patients was 28.1% as compared to 7.1% in D-dimer negative subjects (p = 0.024). D-dimer positive patients had significantly greater frequencies of venous thromboses (21.9% vs 4.8%, p = 0.035).
CONCLUSIONS:
The D-dimer assay identifies patients at increased risk for mortality and may be a more sensitive test to determine the presence of underlying microvascular pathology in critically ill patients. A positive D-dimer at admission to the MICU is associated with an increased risk for the later development of a venous thromboembolic event (VTE).
AuthorsA F Shorr, R F Trotta, S A Alkins, G S Hanzel, L F Diehl
JournalIntensive care medicine (Intensive Care Med) Vol. 25 Issue 2 Pg. 207-10 (Feb 1999) ISSN: 0342-4642 [Print] United States
PMID10193549 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
Topics
  • APACHE
  • Aged
  • Biomarkers
  • Cohort Studies
  • Disseminated Intravascular Coagulation
  • Female
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Hospital Mortality
  • Humans
  • Intensive Care Units
  • Latex Fixation Tests
  • Logistic Models
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Venous Thrombosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: